Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible?
Introduction: Allogeneic hematopoietic stem cell transplantation (HSCT) is a major curative treatment option for malignant and non-malignant hematological diseases, but is associated with an increased risk for infections, of which some are preventable by vaccination. Vaccination guidelines recommend...
Saved in:
Main Authors: | Anne Conrad (Author), Vincent Alcazer (Author), Florent Valour (Author), Florence Ader (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
by: Angelo Atalla, et al.
Published: (2013) -
Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
Published: (2020) -
Unusual gingival actinomycosis post allogeneic hematopoietic stem-cell transplant: case report
by: Julia Stephanie Bruno, et al.
Published: (2023) -
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
by: Solange dos Santos Moragas Barbosa, et al.
Published: (2014) -
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
by: Solange dos Santos Moragas Barbosa, et al.
Published: (2014)